A brief overview of global evidence in support of the consumption of EPA and DHA in the prevention of Heart Disease.

11 April 2019 (12:50 - 13:00)

Organised by:

About the speaker

Doctor Aldo Bernasconi

Salt Lake City (United States of America)

3 More presentations in this session

Presentation thumbnail

Introduction - An update on the evidence regarding the beneficial effects of the consumption of marine omega 3 fatty acids with regard to prevention of primary cardiovascular disease.

Doctor R. Winwood (Kaiseraugst, CH)

Presentation thumbnail

Supporting evidence for the cardio-protective role of long chain omega-3 PUFA is on a sticky wicket right now, but these fatty acids are definitely not out!

Professor B. Briffin (Guildford, GB)

Presentation thumbnail

Studies of studies: understanding and critiquing a meta-analysis.

Associate Professor M. Wiest (Moscow, US)

Access the full session

Session thumbnail

An update on the evidence regarding the beneficial effects of the consumption of marine omega 3 fatty acids with regard to prevention of primary cardiovascular disease.

The Event

EuroPrevent 2019

11 April 2019 12:50 CET

You may be interested in

Congress Presentation

Cardiovascular risk reduction & hypertriglyceridemia: integrating the evidence

29 August 2025

Congress Presentation

European Union: how can we drive change?

1 September 2025

Congress Presentation

EPA:DHA 6:1 prevents right ventricular dysfunction and lung vascular remodeling in monocrotaline-induced pulmonary arterial hypertension in rats by mitigating inflammatory and pro-oxidant responses

18 May 2025

Webinar

Arrhythmias and metabolic pathways: new mechanisms, new opportunities

2 June 2022

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources